Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Eniola Odetunde/Axios

U.K.-based health tech company Bioniq will announce on Wednesday a $7.8 million Series A investment led by venture capital firm OKS Group for a U.S. and Middle East expansion.

The big picture: Bioniq, a supplement subscriptions and at-home testing services company, is among the many health-tech companies that have seen a boom in demand during the pandemic.

  • Bioniq has partnered with Lenco Diagnostic Laboratories in more than 20 locations across the East Coast, along with doctors and a fitness club chain.

The state of play: Public anxiety surrounding COVID-19 has pushed health and wellness concerns to the forefront, with some studies pointing to the benefits of dietary supplements as a possible immune system defense.

  • This convergence of skyrocketing Vitamin C and Vitamin D sales and closed doctors' offices have caused health startups to swoop in with personalized supplements, health quizzes and digital consultations.

Between the lines: As coronavirus cases increase in the U.S. and some parts of the globe, there are limited options for therapeutics with mass availability, and digital health care companies will continue to cash in on people trying to get ahold of these products.

Go deeper

Dan Primack, author of Pro Rata
Jan 21, 2021 - Economy & Business

COVID-19 vaccine: Private companies step in to fill logistics vacuum

Illustration: Annelise Capossela/Axios

Last year we wrote several times about how VC-backed companies were helping to fight the COVID-19 pandemic, including vaccine development and innovative testing solutions. Now the same thing is happening when it comes to vaccinations, a process beset by logistics and planning problems since the jump.

Driving the news: Carbon Health, a tech-enabled healthcare startup that recently raised $100 million in Series C funding, is now the primary back-end for vaccinations in the City of Los Angeles, including a massive drive-up program that just launched in the parking lot of Dodger Stadium.

Chauvin defense closing: "Does not have to prove his innocence"

Chauvin's defense attorney Eric Nelson opened his closing argument on Monday by reminding the jury that Derek Chauvin "does not have to prove his innocence."

Why it matters: The jury's verdict in Chauvin's murder trial is seen by advocates as one of the most crucial civil rights cases in decades.

Merrick Garland: Domestic terror is "still with us"

Photo: Kevin Dietsch/UPI/Bloomberg via Getty Images

In his first major speech, Attorney General Merrick Garland warned the nation Monday to remain vigilant against the rising threat of domestic extremism.

Why it matters: Domestic terrorism poses an "elevated threat" to the nation this year, according to U.S. intelligence. Garland has already pledged to crack down on violence linked to white supremacists and right-wing militia groups.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!